HCPCS Level IIdrugActive
J0701
Inj. cefepime hcl (baxter)
BETOS: O1E
Effective: 2024-01-01
Description
Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Cefepime HCl
Manufacturer
Baxter Healthcare Corporation
HCPCS Dosage
500 MG
Billing Units
2.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.